{"id":"W2587349694","doi":"10.18192/uojm.v7i1.1563","title":"Triple Negative Breast Cancer: A review of common therapeutic Targets and Current Treatment options.","year":2017,"lang":"en","type":"review","venue":"University of Ottawa Journal of Medicine","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Triple-negative breast cancer; Carboplatin; Breast cancer; Oncology; Internal medicine; Cancer; Chemotherapy; Clinical trial; Bevacizumab; Adjuvant; Cancer research; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004773272,0.0003580872,0.004030403,0.0003831179,0.00009518547,0.000002009673,0.0003108666,0.000109529,0.0004267416],"category_scores_gemma":[0.00006551004,0.0002413714,0.0005248974,0.0001760103,0.0008322882,0.0001247406,0.00004609196,0.0004134845,9.33851e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004932865,"about_ca_system_score_gemma":0.0008454414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000241836,"about_ca_topic_score_gemma":0.00002983435,"domain_scores_codex":[0.9981198,0.00020641,0.0008417189,0.0001983042,0.0004603909,0.0001734225],"domain_scores_gemma":[0.9949319,0.0001805764,0.003642988,0.0003926308,0.0006249269,0.0002270261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001536656,0.000200969,0.0000807927,0.04448803,0.001289048,0.00007028462,0.0002982682,2.056134e-7,0.000001331665,0.00005027256,0.0006689443,0.9526982],"study_design_scores_gemma":[0.003816066,0.0008067762,0.0003412815,0.2700059,0.006630464,0.001042961,0.0001389112,7.782814e-7,0.000001438594,0.00003086197,0.7170753,0.0001093058],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006672283,0.9964015,0.00008867666,0.002112736,0.0003028422,0.0007232768,0.0001740367,0.000005103508,0.000185101],"genre_scores_gemma":[0.00006557981,0.999031,0.0003039392,0.00005374371,0.0002743721,9.181893e-7,0.00002100939,0.00002245635,0.0002269848],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9525889,"threshold_uncertainty_score":0.9842839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07844334886115388,"score_gpt":0.3885889983004034,"score_spread":0.3101456494392495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}